| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/02/2000 | CA2338837A1 Assays, methods and means for modulating nuclear localisation |
| 03/02/2000 | CA2337905A1 Targeted alphavirus and alphaviral vectors |
| 03/01/2000 | EP0982405A2 Recombinant alphavirus vectors |
| 03/01/2000 | EP0982400A1 Human glycine transporter |
| 03/01/2000 | EP0982399A1 Thyroid hormone transporters, agonists and antagonists thereof |
| 03/01/2000 | EP0981649A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
| 03/01/2000 | EP0981648A1 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES |
| 03/01/2000 | EP0981636A1 Lentivirus-based gene transfer vectors |
| 03/01/2000 | EP0981620A1 Hgf polypeptides and their use in therapy |
| 03/01/2000 | EP0981612A2 Secreted proteins and polynucleotides encoding them |
| 03/01/2000 | EP0981610A2 Compositions for treatment of disorders involving programmed cell death |
| 03/01/2000 | EP0981549A1 A method for the improvement of neuronal regeneration |
| 03/01/2000 | EP0981367A1 Immunization against endogenous molecules |
| 03/01/2000 | EP0981357A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 03/01/2000 | EP0981331A1 The use of temperature to control the size of cationic liposome/plasmid dna complexes |
| 03/01/2000 | CN1246158A Method of PCR testing of pooled blood samples |
| 02/29/2000 | US6031090 Molecular cloning of a 7TM receptor (GPR31A) |
| 02/29/2000 | US6031076 Conservin compositions |
| 02/29/2000 | US6030956 Vector to kill cancer cells in a variety of human malignancies |
| 02/29/2000 | US6030949 Macrophage stimulating protein for the treatment of pathologies of the nervous system |
| 02/29/2000 | US6030837 Antisense inhibition of PEPCK-mitochondrial expression |
| 02/29/2000 | US6030836 Concurrent culturing of human mesenchymal stem cells with hematopoietic stem cells to retain stem cell phenotype |
| 02/29/2000 | US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030804 Nucleotide and amino acid sequences; for prevention and/or treatment of osteoporosis, hypercalcemia, hypoparathyroidism, hypophosphatemia, kidney stones, nephrolithiasis, and chronic tetany |
| 02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
| 02/29/2000 | US6030638 Plasmid for in vivo expression of prostaglandin synthase |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030615 Combination method for treating diseases caused by cytokine-mediated toxicity |
| 02/29/2000 | CA2050072C Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
| 02/28/2000 | CA2281442A1 Use of a cationic polymer for the preparation of a complex with nucleic acid and related compositions |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/24/2000 | WO2000009734A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | WO2000009731A1 Transgenic parasites as gene therapy agents |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009713A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009700A1 Rna virus vector having contact infiltration capability |
| 02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 02/24/2000 | WO2000009675A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | WO2000009669A1 Human mesencephalon cell lines and methods of use therefor |
| 02/24/2000 | WO2000009668A1 Engraftable human neural stem cells |
| 02/24/2000 | WO2000009667A1 Calcineurin-dependent control of skeletal muscle fiber type |
| 02/24/2000 | WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | WO2000009556A1 Human lysophospholipase gene (cbfblh05) |
| 02/24/2000 | WO2000009555A1 A human gene hspc021 (cbfaig06) |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | WO2000009532A1 Methods and compositions for modulating transcription by use of antibodies to transcription factors |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009167A1 Virally-mediated targeting of drugs and genetic material |
| 02/24/2000 | WO2000009153A1 Compositions and methods for treating lysosomal storage disease |
| 02/24/2000 | WO2000009148A1 Vascular endothelial growth factor 3 |
| 02/24/2000 | WO2000009145A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000009070A2 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | WO1999065461A3 Cationic amphiphile micellar complexes |
| 02/24/2000 | WO1999064565A3 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 02/24/2000 | WO1999049774A9 Methods for the diagnosis and treatment of lung cancer |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | WO1999009139A9 Retrovirus and viral vectors |
| 02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
| 02/24/2000 | DE19828624C1 Modular aufgebaute RNA-Moleküle mit zwei Sequenzbereichstypen Modular RNA molecules with two types of sequence region |
| 02/24/2000 | CA2340682A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | CA2340176A1 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339779A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | CA2339302A1 Vascular endothelial growth factor 3 |
| 02/24/2000 | CA2339300A1 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2305768A1 Compositions and methods for treating lysosomal storage disease |
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/23/2000 | EP0980433A1 Uncoupling protein homologue: ucp 3 |
| 02/23/2000 | EP0980428A2 TECHNIQUES AND COMPOSITIONS FOR TREATING HEART FAILURE AND VENTRICULAR REMODELING BY $i(IN VIVO) DELIVERY OF ANGIOGENIC TRANSGENES |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980264A2 Mammalian cell transduction for use in gene therapy |
| 02/23/2000 | EP0980263A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 02/23/2000 | EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
| 02/23/2000 | CN1245536A Novel calpaines, production and use thereof |
| 02/22/2000 | US6028188 Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages |
| 02/22/2000 | US6028184 For transgenic cells; for diagnosis of hypoglycemia, psychological and brain disorders; antidiabetic/hyperglycemic agents |
| 02/22/2000 | US6028169 Chemokine β-6 antagonists |
| 02/22/2000 | US6028059 Methods for modulating protein function in cells using intracellular antibody homologues |
| 02/22/2000 | US6027935 Gene up-regulated in regenerating liver |
| 02/22/2000 | US6027905 Methods for the detection of cervical cancer |
| 02/22/2000 | US6027722 Vectors for gene transfer |
| 02/22/2000 | US6027721 Delivery of a biocompatible capsule comprising a core comprising living packaging cells that secrete a retroviral vector for infection of a target cell, comprising a heterologous gene encoding a biologically active molecule |
| 02/22/2000 | US6027488 Flow-through electroporation system for ex vivo gene therapy |
| 02/22/2000 | CA2176713C Amphiphilic imidazolinium derivatives |
| 02/22/2000 | CA2091882C Gene therapy for cystic fibrosis |
| 02/17/2000 | WO2000008199A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 02/17/2000 | WO2000008196A2 Urate oxidase |
| 02/17/2000 | WO2000008194A2 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | WO2000008193A2 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | WO2000008192A2 Herpesviral vectors for gene delivery |